Found 5 matching trials
Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia PHASE1 This study is an open-label, single-arm clinical trial designed to evaluate...
Show More Location
The first affiliated hospital of fujian medical university
Learn More & Join Trial
Clinical Study of Universal CAR-γδT Cell Injection in the Treatment of Patients With Relapsed AML After Transplantation NA This is an open single-arm clinical study aimed at evaluating the efficacy ...
Show More Location
Hebei yanda Ludaopei Hospital
Learn More & Join Trial
UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies. EARLY_PHASE1 This study is designed for exploring the preliminary safety and efficacy of...
Show More Location
The First Affiliated Hospital of USTC (AnHui Provincial Hospital)
Learn More & Join Trial
Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma PHASE1 This study is an open-label, single-arm clinical trial designed to evaluate...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. PHASE1 This study is an open-label, exploratory, prospective clinical trial with d...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial